1 results match your criteria: "Hospital del Mar-IMIM. Barcelona. jhorcajada@psmar.cat.[Affiliation]"
Rev Esp Quimioter
September 2021
Juan P. Horcajada, Department of Infectious Diseases, Hospital del Mar-IMIM. Barcelona.
Ceftolozane-tazobactam is currently the most active antipseudomonal agent, including multidrug-resistant extensively drug-resistant strains. Tazobactam provides additional activity against many extended-spectrum beta-lactamases Enterobacterales. Ceftolozane-tazobactam is formally approved for complicated urinary tract infection, complicated intra-abdominal infection, and hospital-acquired and ventilator-associated bacterial pneumonia.
View Article and Find Full Text PDF